Tevogen Bio Holdings Inc (TVGN)

Currency in USD
1.010
+0.017(+1.74%)
Real-time Data·
TVGN Scorecard
Full Analysis
Suffers from weak gross profit margins
TVGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.9801.020
52 wk Range
0.2563.090
Key Statistics
Prev. Close
0.993
Open
0.987
Day's Range
0.98-1.02
52 wk Range
0.256-3.09
Volume
172.04K
Average Volume (3m)
649.57K
1-Year Change
77.01%
Book Value / Share
-0.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TVGN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.000
Upside
+890.10%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Tevogen Bio Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Tevogen Bio Holdings Inc Company Profile

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Compare TVGN to Peers and Sector

Metrics to compare
TVGN
Peers
Sector
Relationship
P/E Ratio
−6.2x−3.7x−0.5x
PEG Ratio
−0.070.010.00
Price/Book
−11.8x2.8x2.6x
Price / LTM Sales
-158.4x3.3x
Upside (Analyst Target)
-168.3%43.5%
Fair Value Upside
Unlock−1.5%6.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.000
(+890.10% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.07 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TVGN Income Statement

People Also Watch

17.09
SRPT
-0.06%
0.98
KLTO
-1.85%
159.61
CRCL
-3.16%
13.68
OSCR
-1.17%
45.540
SMR
+4.98%

FAQ

What Stock Exchange Does Tevogen Bio Holdings Trade On?

Tevogen Bio Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tevogen Bio Holdings?

The stock symbol for Tevogen Bio Holdings is "TVGN."

What Is the Tevogen Bio Holdings Market Cap?

As of today, Tevogen Bio Holdings market cap is 192.26M.

What Is Tevogen Bio Holdings's Earnings Per Share (TTM)?

The Tevogen Bio Holdings EPS (TTM) is -0.20.

From a Technical Analysis Perspective, Is TVGN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Tevogen Bio Holdings Stock Split?

Tevogen Bio Holdings has split 0 times.

How Many Employees Does Tevogen Bio Holdings Have?

Tevogen Bio Holdings has 18 employees.

What is the current trading status of Tevogen Bio Holdings (TVGN)?

As of 05 Aug 2025, Tevogen Bio Holdings (TVGN) is trading at a price of 1.01, with a previous close of 0.99. The stock has fluctuated within a day range of 0.98 to 1.02, while its 52-week range spans from 0.26 to 3.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.